Acronym
MoST 12 (substudies 27-30)
Project Title
Single arm, open label, phase II trial of vemurafenib and cobimetinib in patients with advanced tumours harbouring BRAF V600 mutations detected by comprehensive genomic profiling
Principal Investigator
Start Date
December 11, 2019
Keywords
Lung Cancer/Other tumours harbouring BRAF V600 mutations
Project Type
Interventional/Clinical trials research
